SNA-006

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameSNA-006
Drug Alias Name68-Ga-NODAGA-SNA-00668Ga-NODAGA-SNA006SNA-006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsDiagnostic agent (In vivo) +[6] 
Mechanisms of ActionDiagnostic imaging enhancersPositron-emission tomography enhancersRadionuclide imaging enhancers +[4] 
TargetsCluster of differentiation 8
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSmartnuclide Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesFirst Hospital Affiliated To China Medical UniversitySmartnuclide Biopharma
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A